Buscar
Mostrando ítems 1-10 de 81
Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis
(2016-10-01)
Aims: Multiple sclerosis (MS) is an immune-mediated demyelinating disorder of the central nervous system (CNS). We described that Candida albicans (Ca) aggravates experimental autoimmune encephalomyelitis (EAE) that is a ...
Tolerogenic Vaccination With Mog/vitd Overcomes Aggravating Effect Of C-albicans In Experimental Encephalomyelitis
(Wiley-BlackwellHoboken, 2016)
Therapeutic potential of hyporesponsive CD4+ T cells in autoimmunity
(Frontiers Media S.A., 2015)
© 2015 Maggi, Schafer, Ubilla-Olguín, Catalán, Schinnerling and Aguillón. The interaction between dendritic cells (DCs) and T cells is crucial on immunity or tolerance induction. In an immature or semi-mature state, DCs ...
Regulation of tolerogenic features on dexamethasone-modulated MPLA-activated dendritic cells by Myc
(Frontiers Media S.A., 2019)
Copyright © 2019 García-González, Maggi, Schinnerling, Sepúlveda-Gutiérrez, Soto, Neira, Mehdi, Nel, Pesce, Aravena, Molina, Catalán, Thomas, Verdugo and Aguillón.The potential of tolerogenic dendritic cells (tolDCs) to ...
Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: an emerging role of protein-glycan interactions
(Karger, 2010-12)
During the past decade, a great deal of information has contributed to our understanding of the immunosuppressive pathways that operate during the resolution of autoimmune pathology, including central nervous system (CNS) ...
Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development
(2016-03-11)
Multiple sclerosis is a chronic, inflammatory and demyelinating disease of the central nervous system (CNS). As there is no cure for this disease, new therapeutic strategies and prophylactic measures are necessary. We ...
Tolerogenic Dendritic Cells On Transplantation: Immunotherapy Based On Second Signal Blockage
(HINDAWI PUBLISHING CORPNEW YORK, 2015)
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies
(2016)
Cellular therapies, with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation The methodologies ...